Vanessa Lee

12/13/2022

IVI conducts on-site training, consultation for Afrigen in South Africa

Provides training for about 40 Afrigen personnel on overall biopharmaceutical production as part of GTH-B program     December 13, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) conducted on-site training and consultation for Afrigen Biologics & Vaccines (Afrigen) in South Africa to help […]
11/22/2022

Invitation for Bid: Purchase of Tangential Flow Filtration (TFF) system

INVITATION FOR BID [Purchase of Tangential Flow Filtration (TFF) system] The International Vaccine Institute (IVI) now invites sealed proposals from interested parties for the supply of the following goods and/or services: Ref. No: IVI-DVT/2022-1122 Deadline for proposal submission: 17:00 on Dec 5, 2022, KST (GMT […]
11/10/2022

Lemonex, IVI exchange MOU on joint vaccine development

November 10, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development. IVI and Lemonex […]
10/14/2022

Invitation for Bid: Purchase of Chromatography System

INVITATION FOR BID [Purchase of Chromatography System] The International Vaccine Institute (IVI) now invites sealed proposals from interested parties for the supply of the following goods and/or services: Ref. No: IVI-DVT/2022-1014 Deadline for proposal submission: 17:00 on Oct 27, 2022, KST (GMT + 9 h) […]